Abstract: An incontinence device is insertable into and removable from a vaginal canal of a human user to apply pressure upon a urethra. The incontinence device includes a distal body member having a central core, a first arcuate arm on a first side of the central core and a second arcuate arm on a second opposite side of the central core. The first and second arcuate arms flex inward toward the central core into a first compressed position during insertion and expand outward away from the central core into a second in use position to fill the space in the middle and superior thirds of the vaginal canal in order to retain the incontinence device in the vaginal canal. The incontinence device also includes a proximal pressure member extending from the body member for resilient movement relative to the body member; wherein the pressure member applies pressure to support the urethra for controlling incontinence.

Abstract: An incontinence device is insertable into and removable from a vaginal canal of a human user to apply pressure upon a urethra. The incontinence device includes a distal body member having a central core, a first arcuate arm on a first side of the central core and a second arcuate arm on a second opposite side of the central core. The first and second arcuate arms flex inward toward the central core into a first compressed position during insertion and expand outward away from the central core into a second in use position to fill the space in the middle and superior thirds of the vaginal canal in order to retain the incontinence device in the vaginal canal. The incontinence device also includes a proximal pressure member extending from the body member for resilient movement relative to the body member; wherein the pressure member applies pressure to support the urethra for controlling incontinence.

Abstract: The disclosed invention is based on the discovery that a cell-based therapy can be used to treat, ameliorate, manage and/or reduce the progression of clinical sequelae associated with vascular interventions or cardiovascular diseases, particularly occlusive thrombosis, restenosis, intimal hyperplasia, inflammation and vasodilation. The invention further benefits from the additional discovery that a heretofore undescribed implantable flowable composition is capable of sustaining a confluent population of sufficiently viable cells which can be effectively administered via a minimally-invasive surgical procedure without diminishing the clinical effectiveness or the viability of the cells. The disclosed invention can be used to treat vasculature as well as non-vascular tubular structures such as a fallopian tube.

Abstract: A window subassembly for installation with insulated concrete forms is disclosed. The window subassembly comprises opposing side panels secured to top and bottom panels that collectively define an interior boundary adapted to receive a window. The bottom panel includes a slope member that functions as a window sill to divert rain flow away from the window. In another embodiment, the window subassembly further comprises an air conditioning sub-assembly adapted to engage an air conditioning unit.